# Prestige BioPharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prestige-biopharma

- Industry: Biotechnology
- Headquarters: Singapore
- Website: www.prestigebiopharma.com
- Total disclosed funding: $114M
- Latest round: Series B (Oct 29, 2019)
- Investors on record: 4

## About

Founded in 2015 and based in Singapore, Prestige BioPharma Ltd is a biopharmaceutical company that develops antibody therapeutics and biosimilars for treating tumors and immune disorders.

## Funding rounds

- Series B, Oct 29, 2019, $72M — KB Securities, Octava, CQ Capital
- Series A, Jan 31, 2019, $42M — Polo equity Partners, Octava

## Investors

- Polo equity Partners (https://capitalatlas.ai/funds/polo-equity-partners) — Series A
- Octava — Series A, Series B
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series B
- CQ Capital — Series B